Clinical trials
3 active studies led by Ion Beam Applications, of 3 in all
Source: ClinicalTrials.gov, Studies with Ion Beam Applications (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 3Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Ion Beam Applications or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Ion Beam Applications
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Website
- iba-worldwide.com
- Home country
- Belgium
- Type
- Medical devices
Source: Wikidata, Company record Q28195227. Retrieved 13 Nov 2026.
See them on ClinicalTrials.gov (opens in a new tab)
US device clearances
1 510(k) clearances and PMA approvals since 2015
- Iba Proton Therapy System- Proteus 235 (Proteus One, Proteus Plus, Proteus Tk2,… K163500 · 17 Aug 2017
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
US recalls
33 recalls since 2015 (33 for devices)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Retrieved 13 Nov 2026.
Trials over time
Studies Ion Beam Applications leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Ion Beam Applications or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Ion Beam Applications: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Ion Beam Applications is in.
From our blog
Stories on the topics Ion Beam Applications works in.
Brain Cancer Diagnosis: Imaging and New Biomarkers
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Bioinformatics: Making Sense of Health Data
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read
Dermatology Diagnostics: AI and Skin Health
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read